Pycnogenol® Normalizes Cardio Risks During Perimenopause

Overview


Pycnogenol-R-Normalizes-Cardio-Risks-During-Perimenopause.png

A new study builds upon previous research showing the benefits of Pycnogenol® for alleviating perimenopause symptoms and is the first study to show effects on cardiovascular risk markers, homocysteine and CRP levels.

Daily Pycnogenol® supplementation reduced and normalized elevated cardiovascular risk factors often related to perimenopause: cholesterol, triglycerides, blood pressure and blood glucose. Participants also reported significant relief of hot flashes, reduction of night sweats and mood improvement.

This content is provided by Horphag Research, and any views and opinions expressed do not necessarily reflect those of NutraIngredients-USA.com

Download Now


Related Resources

Robuvit® French Oak Wood Extract for Energy

Robuvit® French Oak Wood Extract for Energy

Content provided by Horphag Research

White Paper

Just like a car needs fuel to run, our bodies need energy to perform every single function—from simple tasks like blinking to complex processes like thinking or immune defence.

Pycnogenol® Alleviates Cellulite in Women

Pycnogenol® Alleviates Cellulite in Women

Content provided by Horphag Research

Research Study

 A new double-blind, placebo‐controlled study reveals that daily supplementation with Pycnogenol®, French maritime pine bark extract, reduces cellulite severity—a very common skin condition, most prevalent in women, linked to dermal structure and...

Supplier Info Centre

Horphag-Research.jpg

For more product information visit Horphag Research.